NZ dollar rides optimism on unproven covid-19 treatment

NZ dollar rides optimism on unproven covid-19 treatment
Jenny Ruth
The New Zealand dollar rode a wave of optimism about a still-unproven covid-19 treatment which has been driving equities markets higher. At the same time, the market has been ignoring worse than expected US March-quarter GDP data and a downbeat economic assessment from the Federal Reserve. The kiwi was trading at 61.44 US cents at 5pm in Wellington from 60.93 cents at the same time yesterday. The trade-weighted index was at 69.11 from 68.78. Biopharmaceutical company Gilead has been talking up Remdesivir, a drug which proved ineffectiv...

More Markets

NZ sharemarket up 0.4% to end the week
Markets Market close

NZ sharemarket up 0.4% to end the week

The S&P/NZX 50 Index closed at 11,794.81, up 48.15 points or 0.41%.

Graham Skellern 05 Jul 2024
Australian shares rally as dollar hits six-month high
Markets Aus Market Wrap

Australian shares rally as dollar hits six-month high

The ASX200 has risen 1.2% to hit a nine-day high.

AAP 05 Jul 2024
NZ sharemarket down, Oz and US stocks climb
Markets Market close

NZ sharemarket down, Oz and US stocks climb

The S&P/NZX 50 Index closed at 11,746.66, down 44.26 points or 0.38%.

Graham Skellern 04 Jul 2024
Summerset anticipates flat 1H underlying profit
Markets

Summerset anticipates flat 1H underlying profit

The company is NZ's best-performing retirement village operator.

Gregor Thompson 04 Jul 2024